An in-vitro technique for assessment of thrombogenicity in mechanical prosthetic cardiac valves: Evaluation with a range of valve types

Journal of Heart Valve Disease

Volumn 13, Issue 3, 2004, Pages 509-520

  Martin, Aimee J ^a   Christy, John R E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOSIN; RENNET;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; EVALUATION; HEART VALVE PROSTHESIS; HUMAN; IN VITRO STUDY; MATERIALS TESTING; METHODOLOGY; MILK; PROSTHESIS; PULSATILE FLOW; THROMBOSIS;

ANIMALS; CHYMOSIN; HEART VALVE PROSTHESIS; HUMANS; MATERIALS TESTING; MILK; MODELS, CARDIOVASCULAR; PROSTHESIS DESIGN; PULSATILE FLOW; THROMBOSIS;

EID: 5144219874     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bodnar E. The Medtronic Parallel (TM) valve and the lessons learned. J Heart Valve Dis 1996;5:572-573
2. Joliès P. Structural aspects of the milk clotting process. Comparative features with the blood clotting process. Mol Cell Biochem 1975;7:73-85
3. Lewis JMO, MacLeod N. A blood analogue for the experimental study of flow-related thrombosis at prosthetic heart valves. Cardiovasc Res 1983;17:466-475
4. Petschek H, Adamis D, Kantrowitz AR. Stagnation flow thrombus formation. Trans Am Soc Artif Intern Organs 1968;14:256-259
5. Lewis JMO. A blood analogue for thrombogenicity assessment. PhD thesis, University of Edinburgh, 1981
6. Hladovec H, Riha P. The model of thrombosis and thrombolysis in vitro. Thromb Res 1975;7:743-752
7. Keggen LA, Black MM, Lawford PV. The use of enzyme-activated milk for in vitro simulation of prosthetic valve thrombosis. J Heart Valve Dis 1996;5:74-83
8. Payens TAJ, Wiersma AK, Brinkhuis J. On enzymatic clotting processes I. Kinetics of enzyme-triggered coagulation reactions. Biophys Chem 1977;6:253-261
9. Christy JRE, Marosek KW. Ultrasonic determination of clot deposition rates in a milk-based, in-vitro procedure for thrombogenicity assessment. J Heart Valve Dis 2000;9:379-388
10. Wieting DW, Hall CW, Liotta D, Bakey MED. Dynamic flow behavior of artificial heart valves. In Brewer LA (ed.), Prosthetic heart valves. C C Thomas, Springfield, IL, 1969:34-51
11. Miller DC, Oyer PE, Mitchell RS, et al. Performance characteristics of the Starr-Edwards model 1260 aortic valve prosthesis beyond ten years. J Thorac Cardiovasc Surg 1984;88:193-207
12. Metzdorff MT, Grunkemeier GL, Pinson CW, Starr A. Thrombosis of mechanical cardiac valves: A qualitative comparison of the silastic ball valve and the tilting disc valve. J Am Coll Cardiol 1984;4:50-53
13. Harjula A, Mattila S, Maamies T, et al. Long-term follow-up of Björk-Shiley mitral valve replacement: 10 years' experience. Scand J Thorac Cardiovasc Surg 1986;20:79-84
14. Björk VO, Henze A. Management of thromboembolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Scand J Thorac Cardiovasc Surg 1975;9:183-191
15. Moreno-Cabral RJ, McNamara JJ, Mamiya RT, Brainard SC, Chung GKT. Acute thrombotic obstruction with Björk-Shiley valves. J Thorac Cardiovasc Surg 1978;75:321-330
16. Copans H, Lakier JB, Kinsley RH, Colsen PR, Fritz VU, Barlow JB. Thrombosed Björk-Shiley mitral prostheses. Circulation 1980;61:169-174
17. Ben-Zvi J, Hildner FJ, Chandraratna PA, Samet P. Thrombosis on Björk-Shiley aortic valve prosthesis. Am J Cardiol 1974;34:538-544
18. Burgess M, Millane T, Deiraniya A. Acute thrombosis in an aortic prosthesis: All mechanical valves are not the same. Hosp Med 2001;62:788-789
19. Starek PJK, Beaudet RL, Hall K-V. The Medtronic-Hall valve: Development and clinical experience. Cardiac Surg 1987;1:223-236
20. Sharma N, Graver A, Radotra BD. Prosthetic cardiac valve replacement: Management problems. Asian Cardiovasc Thorac Ann 1998;6:179-182
21. Li H-H, Jeffrey RR, Davidson KG, Seifert D, Körfer R, Grunkemeier GL. The Ultracor tilting disc heart valve prosthesis: A seven-year study. J Heart Valve Dis 1998;7:647-654
22. Tasdelen A, Ikizler C, Aslamaci S, Yavari A, Ekici E, Arslan G. Three-year experience with the Ultracor valve prosthesis. Asian Cardiovasc Thorac Ann 1998;6:265-269
23. Nuñez L, Iglesias A, Sotillo J. Entrapment of leaflet of St. Jude Medical cardiac valve prosthesis by miniscule thrombus: Report of two cases. Ann Thorac Surg 1980;29:567-569
24. Kayali MT, Fetieh MW, Abdulsalam MA, Memon F, Moinuddin M, Raffa H. Thrombotic obstruction of bileaflet mechanical prosthetic heart valves: Early diagnosis and management. J Cardiovasc Surg 1998;39:331-335
25. Al-Halees Z, Kumar N. Thrombotic obstruction of bileaflet valves: Surgical management and fiberoptic thrombectomy. Ann Thorac Surg 1994;58:168-169
26. Bowen TE, Tri TB, Wortham DC. Thrombosis of a St. Jude Medical triscuspid prosthesis. J Thorac Cardiovasc Surg 1981;82:257-262
27. Prabhu S, Friday KJ, Reynolds D, Elkins R, Lazzara R. Thrombosis of aortic St Jude valve. Ann Thorac Surg 1986;41:332-333
28. Hirsch R, Soldky A. Recurrent thrombosis of bileaflet prosthetic valves. Circulation 1996;93:2088
29. Montorsi P, Cavoretto D, Ballerini G. Thrombosis of mechanical heart valve prostheses: Revisiting the role of fluoroscopy. Br J Radiol 2000;73:76-79
30. Deuvaert FE, Dumont N, Primo GC. Fluoroscopic differentiation between leaflet escape (LE) and valve thrombosis (VT) of the Edwards-Duromedics mitral valve. Acta Cardiol 1989;44:221-228
31. Koppensteiner R, Moritz A, Moidl R, et al. Blood rheology in patients with native heart valve disease and after valve replacement. Am J Cardiol 1998;81:250-252
32. Goldsmith IRA, Blann AD, Patel RL, Lip GYH. Effect of aortic valve replacement on plasma soluble p-selectin, von Willebrand factor, and fibrinogen. Am J Cardiol 2001;87:107-110
33. Koppensteiner R, Moritz A, Schlick W, et al. Blood rheology after cardiac valve replacement with mechanical prostheses or bioprostheses. Am J Cardiol 1991;67:79-83
34. Christy JRE, MacLeod N. The role of stasis in the clotting of blood and milk flows around solid objects. Cardiovasc Res 1989;23:949-959
35. Walker PG, Yoganathan AP. In vitro pulsatile flow hemodynamics of five mechanical aortic heart valve prostheses. Eur J Cardiothorac Surg 1992;6(Suppl. 1):S113-S123
36. Giddens DP, Yoganathan AP, Schoen FJ. Prosthetic cardiac valves. Cardiovasc Pathol 1993;2:167S-177S
37. Mikaeloff P, Jegaden O, Ferrini M, Coll-Mazzei J, Bonnefoy JY, Rumolo A. Prospective randomized study of St. Jude Medical versus Björk-Shiley or Starr-Edwards 6120 valve prostheses in the mitral position. J Cardiovasc Surg 1989;30:966-975
38. Fiore AC, Barner HB, Swartz MT, et al. Mitral valve replacement: Randomized trial of St. Jude and Medtronic Hall prostheses. Ann Thorac Surg 1998;66:707-713
39. Kuntze CEE, Blackstone EH, Ebels T. Thromboembolism and mechanical heart valves: A randomized study revisited. Ann Thorac Surg 1998;66:101-107
40. Morsi YS, Sakhaeimanesh A, Clayton BR. Hydrodynamic evaluation of three artificial aortic valve chambers. Artif Organs 2000;24:57-63
41. Dale J. Arterial thromboembolic complications in patients with Starr-Edwards aortic ball prostheses. Am Heart J 1976;91:653-659
42. Levine FH, Copeland JG, Morrow AG. Prosthetic replacement of the mitral valve: Continuing assessments of the 100 patients operated upon during 1961-1965. Circulation 1973;47:518-526
43. Akbarian M, Austen WG, Yurchak PM, Scannel JG. Thromboembolic complications of prosthetic cardiac valves. Circulation 196837:826-831
44. Shapira X Sagie A, Jortner R, Adler Y, Hirsch R. Thrombosis of bileaflet tricuspid valve prosthesis: Clinical spectrum and the role of nonsurgical treatment. Am Heart J 1999;137:721-725
45. Roberts WC, Hammer WJ. Cardiac pathology after valve replacement with a tilting disc prosthesis Björk-Shiley type. Am J Cardiol 197637:1024-1033